Climate Change Data

Ondine Biomedical Inc.

Climate Impact & Sustainability Data (2022)

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Antimicrobial Resistance (AMR)
  • Healthcare-associated infections (HAI)
  • Surgical Site Infections (SSI)
  • Environmental impact of manufacturing
  • Workforce diversity and inclusion

Environmental Achievements

  • Began tracking emissions and energy usage in 2022.
  • Comply with regulations for proper disposal of chemical and laboratory waste.
  • Separate office rubbish for recycling.

Social Achievements

  • Grew team from 26 to 43 employees.
  • Ondine workforce: 62% diverse / 40% female
  • Board of Directors: 38% diverse / 25% female
  • Participated in World Antimicrobial Awareness week.

Governance Achievements

  • Continued to enhance Board and governance practices.
  • Board comprised of members – half of whom are Independent Directors.
  • Adopted the Quoted Companies Alliance (QCA) Corporate Governance Code.

Climate Goals & Targets

Long-term Goals:
  • Make photodisinfection the first step in the prevention of HAI.
  • Expand applications across healthcare.
Medium-term Goals:
  • Expand nasal photodisinfection use to other hospital departments (ICU, ER).
  • Leverage existing light sources for additional photodisinfection therapies.
Short-term Goals:
  • Commence FDA Phase 3 clinical trial in 2023.
  • Invest in clinical pilots in UK, Spain, and Mexico.

Environmental Challenges

  • Rising antimicrobial resistance (AMR) and healthcare-associated infections (HAI).
  • Challenges of introducing a completely new disruptive technology.
  • Regulatory hurdles and updating healthcare pathways.
  • COVID-19 disruptions.
  • Supply chain issues.
Mitigation Strategies
  • Rigorous product validation and process-driven approaches.
  • Building a network of key opinion leaders and partners.
  • Securing regulatory approvals in multiple markets.
  • Investing in manufacturing process enhancements and automation.
  • Identifying alternative suppliers and second sources.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Multiple source suppliers
  • Prioritising onshore suppliers

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: IFRS

Certifications: EN ISO 13485:2016, MDSAP

Third-party Assurance: PricewaterhouseCoopers LLP

UN Sustainable Development Goals

  • Goal 3: Good Health and Well-being

Ondine's photodisinfection technology addresses antimicrobial resistance and healthcare-associated infections, contributing to improved global health.

Sustainable Products & Innovation

  • Developing next-generation photodisinfection products utilising LED technology

Awards & Recognition

  • International Photodynamic Association’s Lifetime Achievement Award